Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026)
Pro Dex (PDEX) reported Cash from Financing Activities of $5.5 million for Q1 2026, up 183.59% on a YoY basis from $1.9 million in Q1 2025, and up 209.22% sequentially from -$5.0 million in Q4 2025.
Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Pro Dex (PDEX) has 15 years of Cash from Financing Activities data on file, last reported at $5.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 183.59% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at -$4.5 million (down 524.37% YoY), and the FY2025 full-year result was -$292000.0, up 93.2% from the prior year.
- Cash from Financing Activities improved to $5.5 million in Q1 2026, from -$5.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $5.5 million in Q1 2026 to a low of -$5.0 million in Q4 2025.
- A 5-year average of -$486235.3 and a median of -$853000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 200.54% in 2024, while the deepest fall reached 509.12% in 2024.
- Tracing PDEX's Cash from Financing Activities over 5 years: stood at -$1.5 million in 2022, then soared by 136.88% to $558000.0 in 2023, then jumped by 200.54% to $1.7 million in 2024, then tumbled by 398.21% to -$5.0 million in 2025, then surged by 209.22% to $5.5 million in 2026.
- Business Quant data shows PDEX's Cash from Financing Activities at $5.5 million in Q1 2026, -$5.0 million in Q4 2025, and -$2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Pro Dex | 174.76 Mn | 165.70 Mn | 6.13 Mn | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 558,000.00 |
| Dec 31, 2023 | 558,000.00 |